Literature DB >> 27126040

Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity.

Alexandra Zhernakova1, Alexander Kurilshikov2, Marc Jan Bonder3, Ettje F Tigchelaar4, Melanie Schirmer5, Tommi Vatanen6, Zlatan Mujagic7, Arnau Vich Vila8, Gwen Falony9, Sara Vieira-Silva9, Jun Wang9, Floris Imhann8, Eelke Brandsma10, Soesma A Jankipersadsing3, Marie Joossens11, Maria Carmen Cenit12, Patrick Deelen13, Morris A Swertz13, Rinse K Weersma8, Edith J M Feskens14, Mihai G Netea15, Dirk Gevers16, Daisy Jonkers17, Lude Franke3, Yurii S Aulchenko18, Curtis Huttenhower5, Jeroen Raes11, Marten H Hofker10, Ramnik J Xavier19, Cisca Wijmenga20, Jingyuan Fu21.   

Abstract

Deep sequencing of the gut microbiomes of 1135 participants from a Dutch population-based cohort shows relations between the microbiome and 126 exogenous and intrinsic host factors, including 31 intrinsic factors, 12 diseases, 19 drug groups, 4 smoking categories, and 60 dietary factors. These factors collectively explain 18.7% of the variation seen in the interindividual distance of microbial composition. We could associate 110 factors to 125 species and observed that fecal chromogranin A (CgA), a protein secreted by enteroendocrine cells, was exclusively associated with 61 microbial species whose abundance collectively accounted for 53% of microbial composition. Low CgA concentrations were seen in individuals with a more diverse microbiome. These results are an important step toward a better understanding of environment-diet-microbe-host interactions.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27126040      PMCID: PMC5240844          DOI: 10.1126/science.aad3369

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  52 in total

1.  Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.

Authors:  Andrew Poullis; R Foster; Michael A Mendall; David Shreeve; Keith Wiener
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-05       Impact factor: 2.566

2.  Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.

Authors:  T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

Review 3.  Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.

Authors:  Pascal Crenn; Bernard Messing; Luc Cynober
Journal:  Clin Nutr       Date:  2008-04-28       Impact factor: 7.324

4.  Evaluation of psychosomatic stress in children by measuring salivary chromogranin A.

Authors:  Tsubasa Lee; Toshiaki Shimizu; Megumi Iijima; Kaoru Obinata; Yuichiro Yamashiro; Shingo Nagasawa
Journal:  Acta Paediatr       Date:  2006-08       Impact factor: 2.299

5.  High prevalence of NSAID enteropathy as shown by a simple faecal test.

Authors:  J A Tibble; G Sigthorsson; R Foster; D Scott; M K Fagerhol; A Roseth; I Bjarnason
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

6.  Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.

Authors:  Jost Langhorst; Angela Junge; Andreas Rueffer; Jan Wehkamp; Dirk Foell; Andreas Michalsen; Frauke Musial; Gustav J Dobos
Journal:  Am J Gastroenterol       Date:  2009-01-20       Impact factor: 10.864

7.  Plasma chromogranin a in patients with inflammatory bowel disease.

Authors:  Valentina Sciola; Sara Massironi; Dario Conte; Flavio Caprioli; Stefano Ferrero; Clorinda Ciafardini; Maddalena Peracchi; Maria Teresa Bardella; Luca Piodi
Journal:  Inflamm Bowel Dis       Date:  2009-06       Impact factor: 5.325

8.  Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis?

Authors:  Reena Sidhu; Kaye Drew; Mark E McAlindon; Alan J Lobo; David S Sanders
Journal:  Inflamm Bowel Dis       Date:  2010-03       Impact factor: 5.325

9.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Authors:  Harry Sokol; Bénédicte Pigneur; Laurie Watterlot; Omar Lakhdari; Luis G Bermúdez-Humarán; Jean-Jacques Gratadoux; Sébastien Blugeon; Chantal Bridonneau; Jean-Pierre Furet; Gérard Corthier; Corinne Grangette; Nadia Vasquez; Philippe Pochart; Germain Trugnan; Ginette Thomas; Hervé M Blottière; Joël Doré; Philippe Marteau; Philippe Seksik; Philippe Langella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

10.  Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.

Authors:  Shilpa Joshi; Stephen J Lewis; Siobhan Creanor; Ruth M Ayling
Journal:  Ann Clin Biochem       Date:  2009-09-09       Impact factor: 2.057

View more
  507 in total

1.  The Association between Objectively Measured Physical Activity and the Gut Microbiome among Older Community Dwelling Men.

Authors:  L Langsetmo; A Johnson; R T Demmer; N Fino; E S Orwoll; K E Ensrud; A R Hoffman; J A Cauley; A Shmagel; K Meyer; J M Shikany
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 2.  Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.

Authors:  Mingyang Song; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-18       Impact factor: 11.382

Review 3.  The potential of the microbiota to influence vaccine responses.

Authors:  David J Lynn; Bali Pulendran
Journal:  J Leukoc Biol       Date:  2017-12-28       Impact factor: 4.962

4.  Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.

Authors:  David M Faleck; Hojjat Salmasian; E Yoko Furuya; Elaine L Larson; Julian A Abrams; Daniel E Freedberg
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

5.  Captivity humanizes the primate microbiome.

Authors:  Jonathan B Clayton; Pajau Vangay; Hu Huang; Tonya Ward; Benjamin M Hillmann; Gabriel A Al-Ghalith; Dominic A Travis; Ha Thang Long; Bui Van Tuan; Vo Van Minh; Francis Cabana; Tilo Nadler; Barbara Toddes; Tami Murphy; Kenneth E Glander; Timothy J Johnson; Dan Knights
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

Review 6.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

Review 7.  Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.

Authors:  Panayiotis Louca; Cristina Menni; Sandosh Padmanabhan
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

8.  Structure of the Mucosal and Stool Microbiome in Lynch Syndrome.

Authors:  Yan Yan; David A Drew; Arnold Markowitz; Jason Lloyd-Price; Galeb Abu-Ali; Long H Nguyen; Christina Tran; Daniel C Chung; Katherine K Gilpin; Dana Meixell; Melanie Parziale; Madeline Schuck; Zalak Patel; James M Richter; Peter B Kelsey; Wendy S Garrett; Andrew T Chan; Zsofia K Stadler; Curtis Huttenhower
Journal:  Cell Host Microbe       Date:  2020-04-01       Impact factor: 21.023

9.  Associations Between Race, Perceived Psychological Stress, and the Gut Microbiota in a Sample of Generally Healthy Black and White Women: A Pilot Study on the Role of Race and Perceived Psychological Stress.

Authors:  Tiffany L Carson; Fuchenchu Wang; Xiangqin Cui; Bradford E Jackson; William J Van Der Pol; Elliot J Lefkowitz; Casey Morrow; Monica L Baskin
Journal:  Psychosom Med       Date:  2018-09       Impact factor: 4.312

Review 10.  Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.

Authors:  Eleni Stylianou
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.